China COVID-19 Pandemic Mitigation Products Market – 2020-2024 Report
According to the report, the Chinese cumulative 2020-2024 COVID-19 will be larger than $188 Billion. Furthermore, the Chinese cumulative 2020-2024 market share will be 11.7 % of the global COVID-19 pandemic mitigation products market.
Following a total 83,462 COVID-19 cases, 4,634 deaths and an extremely long lockdown of millions, China is ahead of the curve in its recovery from the recent COVID-19 outbreak, with many provinces slowly returning to normal levels of activity. Factories are restarting production and consumers are beginning to spend again. However, the crisis has had a dramatic and lingering impact on the Chinese economy.
The June outbreak in Beijing has witnessed 260 persons COVID-19 infected was a reminder that a every measure should be taken to mitigate a second wave. According to the COVID-19 Mitigation Products Market -2020-2024 report six elements contributed to the effective containment of the COVID-19 outbreak:
- Lessons learned from past outbreaks. The 2003 SARS, 2009 H1N1 flu and the 2013 H7N9 outbreaks demonstrated the effects of outbreaks. This resulted in funding a restructured healthcare system and the establishment of a pandemic related laboratory network across the country.
- A draconic lockdown of 50 million people.
- China’s Safe City Infrastructure The government invested during 2014-2018 $ billions in a 650 cities’ “Safe City” infrastructure. The core of the “Safe City” system is a people surveillance platforms based on 230 million video cameras, backed by face recognition biometrics.
- The “health code” surveillance infrastructure The Chinese augmented the safe city infrastructure by a so called “health code” service. The “health code” service, running on ubiquitous smart phone’s platforms, was developed for the Chinese government to give users color-coded labels based on their health condition and travel record, and a code that can be scanned by government authorities and millions of establishments. As millions of people in China emerge from a long period of lockdown, their freedom of movement is largely dependent on the “health code” apps .The apps users with a green code are allowed to travel relatively freely. A yellow code indicates that the holder should be in home isolation, and a red one indicates a verified COVID-19 patient who should be in quarantine.
- Chinese citizens (like many in Asia- Pacific countries) culture is to wear face masks when needed.
- “We will invest whatever it takes to contain the outbreak” government policy.
Lessons learned from past viral outbreaks
Due to the 2003 SARS outbreak, the Chinese government has been worried about the potential return of the deadly virus. It restructured the country healthcare system to handle the next outbreak. China extended the laboratory networks to handle the pathogens of infectious diseases; moreover it founded a new laboratory in Wuhan and another laboratory to study pneumonia with uncertain origins.
It is believed that a quicker publication of the epidemic information was a lesson that China learned from the SARS outbreak as the lack of information release worsened the outbreak.
With the improved public health system, China managed to handle several public health emergencies. In coping with the 2009 H1N1 flu outbreak, China developed and distributed vaccines to 100 million people within months as an active prevention. During the 2013 H7N9 outbreak in East China, the country’s health system identified the pathogen five days after the outbreak. Test kits were designed and distributed to all mainland provinces three days after the identification. Within months, effective vaccines were developed. Besides, Chinese academic community was the first to reveal the virus’s transmission methods, molecular mechanisms and effective treatment.
Chinese PPE industry
China manufactures the majority of the globe’s PPE. In Q-1 2020, as the coronavirus tore through China went into lockdown, Chinese PPE factories ramped up production. Then China tried to jump-start the economy. With the pandemic spreading throughout the rest of the world, demand for Personal Protection Gear soared to the point that factory owners in the industry began boasting that they owned money printing machines. As orders of consumer goods shrunk, anxious manufacturers who had the clean rooms and know-how needed to make PPE switched their lines over to make face masks, gloves and PPE gowns.
With demand exploding, full payment up front became the norm. Fraud and counterfeit products proliferated. In April, the PRC government rolled out actions intended to clamp down on counterfeit PPE, and it became even trickier to ship products out of China.
The “health code” service
The Chinese government which invested already billions on advanced people surveillance infrastructure based on 230 million video camera backed by face recognition systems extended this infrastructure to mitigate the pandemic. The extension is called the “health code” service.
The “health code” service is run on the ubiquitous smart phone’s platforms Alipay and WeChat. It was developed for the government to give users color-coded labels based on their health condition and travel record, and a QR code that can be scanned by government authorities.
As millions of peoples in China emerge from a long period of lockdown, their freedom of movement is largely dependent on the “health code” apps.
The apps users with a green code are allowed to travel relatively freely. A yellow code indicates that the holder should be in home isolation, and a red one indicates a verified COVID-19 patient who should be in quarantine.
The apps have become an integral part of Chinese authorities’ supervision of individuals and their movements in and out of affected areas.
The “health code” service app draws on medical information including: COVID-19 related symptoms (e.g., fever, cough), medical treatment, isolated surveillance, contact information, travel record of the pandemic area, user’s travel history including the mode of travel and what seat they sat in, and details on the vehicle and its driver.
The team which composed this report brings 43 years of hands on record in the development and commercialization of healthcare products including: antibody antigen detection, E-health, decontamination and biosecurity, PACS, teleradiology, PPE, computerized tomography, medical devices and more. Our team members bring long term relations with the U.S. FDA and CDC as well as the EU CE and other national medical regulatory agencies.
To adhere to our high standards of research, as nobody can forecast the future of the pandemic, we include in the report two scenarios:
- Optimistic scenario – assumes (among other things) that mass vaccination will commence by July 2021
- Conservative scenario – assumes (among other things) that no mass vaccination will be available until 2025
Why Buy this China COVID-19 Pandemic Mitigation Products Market Report?
A. Questions answered in this report include:
- What is the US COVID-19 Market size and what are the forecast trends during 2020-2024?
- What are the most attractive business opportunities?
- What drives the customers to purchase solutions and services?
- What are the US COVID-19 Market trends?
- What is the 10 sub-markets size over the 2020-2024 period?
- What are the challenges to market penetration & growth?
B. Detailed market analysis frameworks for each of the market sectors are provided, including: